Pfizer-BioNTech vaccine: Fact sheet for recipients and caregivers | Centers for Disease Control and Prevention |
---|---|
Benefits of getting a COVID-19 vaccine | Vaccination considerations for persons with underlying medication conditions |
Moderna announces primary efficacy analysis in phase 3 COVE study for its COVID-19 vaccine candidate and filing today with the U | |
---|---|
V-safe after vaccination health checker | Centers for Disease Control and Prevention |
Neutralization of N501Y mutant SARS-CoV-2 by BNT162b2 vaccine-elicited sera.
mRNA-1273 vaccine induces neutralizing antibodies against spike mutants from global SARS-Cov-2 variants | Officials discuss COVID-19 vaccine deliveries prioritization criteria |
---|---|
Use of Pfizer-BioNTech COVID-19 vaccine: Clinical considerations | Centers for Disease Control and Prevention |